EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Precision Oncology Trials: Navigating the Future of Cancer Care

    Precision oncology is revolutionizing cancer care offering targeted treatments tailored to each patients unique genetic makeup As we navigate the future of cancer care precision oncology trials are paving the way for more effective and personalized treatment options

    Achieving Full Digital Maturity in Pharma Manufacturing: A Paperless Transformation Guide

    The pharmaceutical sector is changing radically as manufacturers do not rely on the past and dataintensive processes The vision of paperless pharma manufacturing is not a dream anymore it is a strategy based on the pressure of the regulators the complexity of operations and the need to accomplish faster and with accuracy production The center of this change is the digital pharma manufacturing and...

    Sustainable Pharma Manufacturing: Eco-Friendly Practices for the Pharmaceutical Industry

    The pharmaceutical business is of significant importance to the healthcare sector all over the world yet it is also among the manufacturing industries that are resourceconsuming Energyintensive production processes complicated chemical synthesis and mass packaging processes have all contributed to pollution and emissions of carbon emissions to the environment as part of the traditional drug manufa...

    Building Resilient Pharma Supply Chains to Strengthen Patient Care

    The failure to deliver a temperaturesensitive biologic or a critical maintenance drug on time is becoming a patient outcome crisis not just an operational inefficiency By fortifying our global logistics networks we proactively safeguard the availability of lifesaving therapies and essential healthcare supplies securing the healthcare industrys central promise to global health This strategic impera...

    From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma

    Over the past decade pharmaceutical organisations have made strong progress in both digitising and digitalising quality operations Systems such as laboratory information management systems LIMS manufacturing execution systems MES and electronic quality management systems eQMS have strengthened traceability embedded workflows and enabled real time visibility across quality processes

    Navigating the EU Biosimilars Regulatory Terrain: A Comprehensive Overview

    In the everevolving landscape of biological medicines biosimilars have emerged as a costeffective alternative to their reference products For market access in the European Union biosimilars must comply

TOP ARTICLES

press releases Read more...

FairJourney Bio Delivers Antibody Engineering for Novel Tumor-Conditional IL-12 Therapeutic Approach That Unlocks the Potential of Localized Cytokine Activation

FairJourney Bio FJBio a global antibody discovery expert today announced the publication of a peerreviewed study in mAbs describing a novel approach with the potential to improve the therapeutic window of IL

Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline

Ipsen announced today it has completed the acquisition of Kartos Therapeutics a clinicalstage biopharmaceutical company adding latestage MDM inhibitor navtemadlin in Phase III clinical development in myelofibrosis

Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases

At the SSIEM Annual Symposium in Helsinki Galen Ltd and POA Pharma announced the launch of Galsana a new global brand for their metabolic product portfolio bringing together established products

Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026

Infex Therapeutics a leading antiinfectives specialist today announced that new Phase IIa study data for RESPX INFEX its firstinclass antivirulence monoclonal antibody therapy in development for NCFB patients

25 - 27

Aug 2026

CPHI Korea 2026

COEX, Seoul, Korea

26 - 27

Aug 2026

BIOMEDevice 2026

Boston Convention & Exhibition...

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

14 - 15

Sep 2026

16th American DDF Summit

Omni Boston Hotel at the Seapo...

15 - 17

Sep 2026

COPD Drug Development Summit 2026

Street, Boston, MA 02210, USA

21 - 23

Sep 2026

21 - 23

Sep 2026

Cancer R&D World Conference

Hilton Garden Inn Miami Dolphi...

LATEST NEWS Read more...

Lupin and Tenpoint Therapeutics partner to commercialise YUVEZZI™ across European markets

Lupin Limited has announced that its wholly owned subsidiary VISUfarma BV has entered into an exclusive licensing agreement with Visus Therapeutics Inc a wholly owned subsidiary of Tenpoint Therapeutics Holding Limited

Rein Therapeutics receives US FDA Fast Track designation for LTI-03 in idiopathic pulmonary fibrosis

Rein Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for LTI an investigational treatment being developed for idiopathic pulmonary fibrosis IPF

IDEAYA Biosciences Announces Clinical Collaboration with Genentech for MTAP-Deleted, KRAS G12D-Mutant Pancreatic Cancer

IDEAYA Biosciences Inc NASDAQ IDYA has entered into a clinical collaboration with Genentech a member of the Roche Group to evaluate IDE in combination with GDC RG in patients

NTx Bio Supports Baylor College of Medicine in Manufacturing Personalised Cancer Vaccine for Phase 1 Melanoma Trial

NTx Bio is supporting Baylor College of Medicine in the manufacturing of a personalised cancer vaccine being evaluated in Diakonos Oncologys Phase trial for patients with refractory melanoma

VectorBuilder and Lir Therapeutics partner to advance AAV capsids for clinical development

VectorBuilder and Lir Therapeutics have entered into a strategic collaboration to develop adenoassociated virus AAV capsids that combine strong biological performance with the manufacturing and scalability requirements needed for clinical development

Cytovance Biologics launches standalone analytical services for biologics development

Cytovance Biologics has expanded its analytical services portfolio to provide standalone analytical support for biotechnology and pharmaceutical companies The new offering gives clients access to Cytovances analytical expertise and regulatoryready solutions without requiring a manufacturing engageme...